# China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial

https://mins.news/en/item/33817

- South China Morning Post, 2026-08-27 02:07 UTC
- Science
- Original: https://www.scmp.com/business/china-business/article/3365384/chinas-akeso-says-cancer-drug-beat-astrazenecas-imfinzi-phase-3-trial?utm_source=rss_feed

> Chinese biopharmaceutical company Akeso said its immunotherapy drug ivonescimab, tested with chemotherapy, outperformed AstraZeneca’s Imfinzi in a head-to-head phase-three trial for biliary tract cancer. The company described the result as another breakthrough as China’s biopharma industry seeks a stronger global position.